CA41917-1 - 0x000000000000616D
Males & Females of Non-Childbearing Potential
Misty
* El estipendio puede pagar hasta el monto reflejado.
Start Date:
April 29, 2024 - 9:15am
End Date:
May 16, 2024 - 10:00am
Study Details
Study Number: CA41917
Group Number: 1
Study Requirement: Healthy Normal Male and Female
Stipend: up to £
No search results
Study Criteria
Age: 18 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat rheumatoid arthritis and pulmonary fibrosis.
Route of Administration: Oral
Blood Draws: 37
Study Schedule
Schedule Type: Long Term
Study Length: 15 Night Stay & 1 Return
Screening Dates:
| Event Day | Event Date | Site |
|---|---|---|
| No search results |
Doctor Exam Dates:
| Event Day | Event Date | Site |
|---|---|---|
| No search results |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Monday | Apr 29 2024 9:15AM | Tuesday | May 14 2024 10:00AM | 1 | Belfast |
| Return | Thursday | May 16 2024 8:30AM | Thursday | May 16 2024 10:00AM | 1 | Belfast |
